CLINICAL ROLE -
Uninsured Patients Pay Much Higher Cost for Cancer Drugs
Private insurers and Medicare patients can pay up to 43 times less than the uninsured.
Read More
Delays in Melanoma Surgery Common Among Medicare Patients
Study finds 1 in 5 Medicare patients have surgery delayed.
Providers Hesitant to Prescribe Pre-Exposure HIV Preventative Regimen
HIV antiviral therapy can prevent infection from establishing in at-risk individuals.
Targeted Cancer Therapy May Also Fight Infections
Enzyme blocker shows potential in treating infections such as Ebola virus.
Improving Drug Adherence in Multiple Sclerosis Patients
Mitra Habibi, PharmD, a clinical pharmacist at the University of Illinois Hospital and Health Sciences System, discusses methods specialty pharmacies can use to enhance adherence in patients with multiple sclerosis.
Better Kidney Transplant Outcomes in Patients with HIV than Hepatitis C
HIV patients need to have undetectable viral load to undergo procedure.
Treatment Target May Improve Brain Cancer Therapy
Glioblastoma Multiforme treatment may extend current one year survival rate.
New Drug Shows Potential in Treatment of Rare Leukemia
Drug could eventually also treat prostate cancer.
In Case You Missed It: Specialty Pharmacy Times Week in Review
A look back at some of the top stories on Specialty Pharmacy Times from March 30 to April 3.
Experimental Cancer Drug May Improves Memory in Alzheimer's Treatment
Drug failed in treatment of solid tumors but shows promise blocking amyloid-beta plaques.
Rosehips Show Promise in Preventing Breast Cancer
Natural extract found to reduce cell growth in triple negative breast cancer.
Hepatitis C Drugs Drive Increase in Average Cost of Specialty Prescription
Specialty drugs comprise 28% of total drug costs from just 1% of claims.
Specialty Drug Approvals Continue to Outpace Traditional Drugs
Anti-infective and cancer drugs saw the most approvals last year.
Fasting with Less Toxic Chemotherapy May be as Effective as Standard Treatments
Less toxic drug class combined with fasting may kill breast, lung, and colon cancer cells equally well.
Genetically Modified Corn Could Lead to Oral Hepatitis B Vaccine
Medication would require no refrigeration and cost less than $1 per dose to manufacture.
Precision Medicine Overcomes Radiation Resistance in Leukemia Treatment
Engineered protein improves survival rates in aggressive leukemia.
Women with Inflammatory Bowel Disease May Have Increased Cancer Risk
Crohn's disease specifically carries greater risk for developing cervical cancer.
New Class of Drugs May Eventually Treat Over 30 Diseases
Compounds that prevent protein aggregation may lead to therapy for conditions such as cancer and diabetes.
Ovarian Cancer Drug Added to Chemotherapy Extends Overall Survival
Standard chemotherapy plus bevacizumab extends survival by a median of 5 months.
Stem Cell Transplant May Enhance Severe Multiple Sclerosis Treatment
Procedure may be more effective than leading drug mitoxantrone.
Compound May Lead to Improved Leukemia Treatments
Researchers believe drug will lead to ‘new paradigm' in leukemia therapy.
HIV Patients Benefit from Exercise for Secondary Illnesses
Moderate to intense exercise carries wide range of benefits.
A look back at some of the top stories on Specialty Pharmacy Times from March 23-27.
Can Hair Loss Be Avoided During Chemotherapy?
Scalp cooling technology seeks to ensure hair retention in most instances.
Avoiding Unnecessary Bowel Cancer Side Effects
Blood test may identify patients who need more intensive chemotherapy.
Smoking Doubles Risk of Prostate Cancer Recurrence After Surgery
Current smokers and those who quit less than 10 years prior to surgery face twice the risk of disease recurrence.
Personalized Bowel Cancer Therapy on the Horizon
Genetic changes in tumors linked to immune system response to disease.
Chemical Found in Insects Improves Cancer Drug
Formic acid from stinging nettles and ants greatly increases treatment's ability to shut down cancer cells.
New Class of Breast Cancer Drugs May Be Effective in Larger Patient Group
Errors in genes may leave tumors susceptible to PARP inhibitors.
Groundbreaking Immunotherapy Shows Promise in Melanoma Treatment
Treatment increases immune response with fewer side effects.